Problems At Pfizer

Problems At Pfizer

There are quite a few factors that are related to the success of Pfizer. First of all, the pain market is continuing to go through a period of sustained growth which is buoyed by a number of new product launches. This could be because of the fact that the pain market has increased by $17 billion in 2001 and is expected to grow to $25 billion by 2010. The growth has been led by their sales of COX-II inhibitors and opioids. Since the market is expected to grow, this will present opportunities in many different drug classes. Pfizer will continue to dominate the pain market over the forecasted period, as the introduction of their second-generation drugs will strengthen their already dominant position. Pfizer recognizes leadership as a core company value. In fact,

pfizer, market, growth, success, pain, factors, expected, drugs, strong, sales, position, population, period, patient, niche, new, leadership, grow, fact, dominant, challenges, billion, been, year, value, top-selling, time, through, sustained, support, strengthen, strategies, starting, spotty, sophisticated, slowing

Leave a reply

Your email adress will not be published. Required fields are marked*